文献速递药物不良反应与药物警戒

国际疾病分类编码识别药物不良事件相关住院的验证研究

The use of international classification of diseases codes to identify hospital admissions linked with adverse drug events: Validation study.
PubMed 文献 · Br J Clin Pharmacol · 2025-06-02

该验证研究分析荷兰一家医院1102例再入院(180例与药物不良事件相关)和捷克一家医院1228例入院(195例相关),比较窄谱与宽谱ICD-10编码集与临床裁定的一致性。窄谱集灵敏度仅3%(95%CI 2-6%),宽谱集升至27%(95%CI 23-32%),特异度由99.6%降至92%。

要点

  • 窄谱ICD-10编码集仅识别3%的药物不良事件相关入院,灵敏度极低。
  • 宽谱编码集将灵敏度提高至27%,特异度仍保持92%。
  • 两套编码集对可预防药物不良事件识别率均更低,不宜单独用于筛查。

核心结论

  • 窄谱ICD-10编码集仅检出3%的药物不良事件相关入院,宽谱集检出27%且特异度无显著下降。
  • 药物不良事件相关ICD编码可作为约四分之一药物不良事件相关住院的触发信号。

研究设计与样本

  • 验证研究,分析荷兰一家医院1102例再入院(180例药物不良事件相关)和捷克一家医院1228例入院(195例相关)。
  • 以专家审查含因果评估的临床裁定为参考标准,计算窄谱与宽谱ICD-10编码集的灵敏度和特异度。

主要发现

  • 窄谱ICD-10集灵敏度3%(95%CI 2-6%),特异度99.6%(95%CI 99-100%)。
  • 宽谱集灵敏度27%(95%CI 23-32%),特异度92%(95%CI 91-94%)。
  • 两套ICD-10编码集对可预防药物不良事件的识别率均更低。

关键数值与推荐

  • 窄谱集定义为药物可能性较高的编码(含「drug-induced」等词)。
  • 宽谱集包括非常可能、可能和或许与药物不良事件相关的ICD-10编码。

临床怎么用

  • 宽谱ICD-10编码集可作为药物不良事件相关住院的触发工具,但灵敏度有限,需结合其他监测方法。
  • 不宜单独依赖ICD编码识别药物不良事件相关入院,尤其对可预防事件。

局限性

  • 仅基于荷兰和捷克两家医院的数据,外推性受限。
  • 临床裁定虽为金标准但人力密集,可能影响参考标准的完整性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Several methods exist to identify hospital admissions related to adverse drug events (ADEs). Clinical adjudication by healthcare professionals is the gold standard but is labour-intensive. Spontaneous reporting and routinely collected healthcare data using a set of International Classification of Diseases (ICD) codes often underestimate the prevalence of ADE-related admissions. Expanding the set of ICD codes could improve detection; however, validation is limited. The objective was to describe the agreement between ADE-related ICD-10 codes and clinically adjudicated ADE-related admissions in 2 settings. METHODS: This study analysed 2 datasets: 1102 readmissions from a hospital in the Netherlands (180 ADE-related) and 1228 admissions from a hospital in the Czech Republic (195 ADE-related). Clinical adjudication involved expert review including causality assessment to identify ADE-related hospital admissions. The sensitivities and specificities were calculated for a narrow code set (higher drug-likelihood codes containing words like drug-induced) and a broad code set of ICD-10 codes (including codes very likely, likely and possibly ADE-related). RESULTS: The narrow ICD-10 set showed a sensitivity of 3% (95% confidence interval [CI] 2-6%) and a specificity of 99.6% (95% CI 99-100%). The broad set increased sensitivity to 27% (95% CI 23-32%), with specificity decreasing slightly to 92% (95% CI 91-94%). Preventable ADEs were identified less frequently with both ICD-10 code sets. CONCLUSIONS: Only 3% of ADE-related admissions were detected by the narrow ICD-code set and 27% by the broad code set without a significant drop in the specificity. ADE-related ICD codes seem to serve as triggers for 1 in 4 ADE-related hospital admissions.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Juhásová Z, Karapinar-Çarkit F, Weir DL, et al. The use of international classification of diseases codes to identify hospital admissions linked with adverse drug events: Validation study. Br J Clin Pharmacol. 2025. PMID: 40452631. doi:10.1002/bcp.70116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。